Loading clinical trials...

Anti-Ageing Health Supplement From Ginger Extracts | Clinical Trials | Clareo Health

COMPLETEDNA

Anti-Ageing Health Supplement From Ginger Extracts

Development of Anti-Ageing Health Supplement From Subcritical Water Extraction of Zingiber Officinale Roscoe (Ginger) Bioactive Compounds

NCT06828783•National University of Malaysia

View on ClinicalTrials.gov

Summary

This study examines the development and efficacy of a health supplement derived from ginger using water extraction. Designed to address aging-related issues such as muscle loss (sarcopenia) and cognitive decline, the capsule's safety and effectiveness were evaluated through clinical trials. Stability testing ensured the capsules maintained their quality under various environmental conditions. Clinical trials further assessed the supplement's antioxidant and anti-inflammatory properties. The findings support its potential benefits for elderly health and aging-related challenges.

Eligibility

Age

48 - 63 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy adult male
•Blood chemistry results specifically Blood Urea Nitrogen (BUN), Serum Creatinine, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Gamma-glutamyl transpeptidase (GGTP), Total Bilirubin and alkaline phosphatase and urinalysis results, specifically urine pH, protein, glucose, ketone, and bilirubin levels within +/- 20% of normal value indicated in the lab report.
•Individuals are willing to maintain their exercise habits and dietary patterns throughout the trial
•No allergy to ginger
•Provide written informed consent before screening
•Subject is willing and able to comply with the study visit schedule and procedure, geographic proximity (investigator's discretion) that allows adequate follow-up
•Subjects understand the study protocol and sign informed consent forms

Exclusion Criteria

•Use of dietary supplements within one week of Day 0. Supplements include any ginger (Zingiber officinale, ginger root, black ginger, zingiberis rhizoma) vitamins, minerals, and herbal products, including herbal drinks.
•Presence of, or clinically significant history of, cancer, cardiovascular, endocrine, kidney, liver, lung, gastrointestinal, metabolic disorder, absorption disorder such as Celiac or Crohn's disease and/or any other chronic health condition such as diabetes identified from the findings of the interview.
•Presence of gallstones or history of gallbladder disease.
•Presence or history of diabetes.
•Presence of cardiovascular disease and hypertension with inconsistent medication regimen, unstable conditions, and without proper physician's - Ten hours before the blood and urine sample collection, subjects should refrain from using medications such as statins (e.g., simvastatin, fluvastatin), NSAIDS including paracetamol, aspirin, nitric oxide (eNOS) activators or inhibitors (e.g., selegiline, Viagra), and angiotensin II receptor blocker (e.g., Telmisartan (blood pressure)) or take any of these medications
•Subjects with vegan diet
•Current smoker or used to smoke in the past 3 months
•Subject for surgery or had undergone surgery in the past 3 months History of bleeding tendencies or any condition predisposing to bleeding e.g. thrombocytopenia, abnormal liver function, liver disease (e.g. chronic hepatitis), gastrointestinal ulcers
•Subjects who have significantly changed their physical activity in the past 2-4 weeks or who intend to change them during the study
•Participation in another clinical trial within 30 days of enrolment into the study.
+1 more criteria

Locations (1)

Hospital Canselor Tuanku Muhriz, UKM Medical Centre

Cheras, WP Kuala Lumpur, Malaysia

Key Dates

Start Date

November 7, 2022

Primary Completion Date

December 31, 2024

Completion Date

December 31, 2024

Last Updated

February 14, 2025

Enrollment

ACTUAL participants

Conditions

Ageing SignsCognitive DeclineMusculoskeletal

Interventions

ginger extract

DIETARY_SUPPLEMENT

Placebo

OTHER

Lombard Cohort of Brain Health Services

NCT07457138

Subjective Cognitive Decline (SCD)Functional Cognitive Disorder+2 more

View study

RECRUITINGNA

Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome

NCT06243848

Musculoskeletal DiseasesMedian Nerve Disease+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 14, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Anti-Ageing Health Supplement From Ginger Extracts

Inclusion Criteria

Exclusion Criteria

Lombard Cohort of Brain Health Services

Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome

The Relationship Between Ultrasonographic Findings and Sleep Quality in Carpal Tunnel Syndrome

Virtual Reality for Shoulder Rehabilitation

Enhancing Attention and Wellbeing Using Digital Therapeutics

Active Pauses for Musculoskeletal Disorder Prevention in Workers